Group 1 - The company Proya announced on January 5 that as of December 31, 2025, it has not yet initiated a stock buyback program, but it plans to implement this buyback based on market conditions in the future [1] - The iMaotai App has surged to the top of the Apple shopping chart, with 100,000 users placing orders for the limited edition Feitian Moutai priced at 1499 yuan, which quickly sold out [1] - The company has reported that distributors are offering the same price as a promotional effort, with 1,000 boxes selling out rapidly [1]

二、 回购股份的进展情况 | 证券代码：603605 | 证券简称：珀莱雅 | 公告编号：2026-002 | | --- | --- | --- | | 债券代码：113634 | 债券简称：珀莱转债 | | 珀莱雅化妆品股份有限公司 关于股份回购进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2025/12/31 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 回购方案实施期限 | 2025 日~2026 | 年 | 12 | 月 | 30 | 年 | 12 | 月 29 日 | | 预计回购金额 | 8,000万元~15,000万元 | | | | | | | | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 □用于转换公司可转债 | | | | | | | | | | □为维护公司价值及股东权益 | | | | | | | | | 累计已回购股数 | ...

| 证券代码：603605 | 证券简称：珀莱雅 | 公告编号：2026-003 | | --- | --- | --- | | 债券代码：113634 | 债券简称：珀莱转债 | | 珀莱雅化妆品股份有限公司 关于回购股份事项前十大股东和前十大无限售条件 股东持股情况的公告 珀莱雅化妆品股份有限公司 董 事 会 2026 年 1 月 6 日 二、前十大无限售条件股东持股情况 | 序号 | 股东名称 | 持股数量（股） | 占无限售条件流通股 | | --- | --- | --- | --- | | | | | 比例（%） | | 1 | 侯军呈 | 136,739,037 | 34.53 | | 2 | 方玉友 | 59,625,258 | 15.06 | | 3 | 香港中央结算有限公司 | 10,572,574 | 2.67 | | 4 | 中国农业银行股份有限公司－中证 500 | 3,552,348 | 0.90 | | | 交易型开放式指数证券投资基金 | | | | 5 | 中国工商银行股份有限公司－中证主要 | 3,445,400 | 0.87 | | | 消费交易型开放式指数证券投资基金 ...

| 证券代码：603605 | 证券简称：珀莱雅 | 公告编号：2026-001 | | --- | --- | --- | | 债券代码：113634 | 债券简称：珀莱转债 | | 珀莱雅化妆品股份有限公司 可转债转股结果暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 累计转股情况：珀莱转债自 2022 年 6 月 14 日开始转股，截至 2025 年 12 月 31 日,累计共有人民币 981,000 元珀莱转债转换为珀莱雅化妆品股份有限公司 （以下简称"公司"）A 股股票，因转股形成的股份数量为 7,212 股，占可转债 转股前公司已发行股份总额的 0.0026%。 未转股可转债情况：截至 2025 年 12 月 31 日，尚未转股的珀莱转债金额为 人民币 750,732,000 元，占珀莱转债发行总量的 99.8695%。 本季度转股情况：自 2025 年 10 月 1 日至 2025 年 12 月 31 日期间，珀莱转 债转股的金额为人民币 6,000 元，因转股形成的股份数量为 6 ...

Core Viewpoint - Proya (603605.SH) has announced that as of December 31, 2025, the company has not yet initiated a stock buyback, but it plans to implement this buyback program based on market conditions in the future [1] Summary by Category - Company Actions - Proya has not commenced any stock buyback as of the specified date [1] - The company intends to evaluate market conditions before proceeding with the buyback plan [1]

Core Viewpoint - The Chinese cosmetics industry is projected to reach a market size of 1.1 trillion yuan, with domestic brands surpassing international brands in market share and consumer preference [1][2]. Group 1: High-Quality Development and New Productive Forces - The domestic cosmetics market retail sales are expected to reach 470 billion yuan by 2025, indicating a significant growth trajectory for the industry [2]. - New productive forces are essential for the high-quality development of the cosmetics industry, transitioning from traditional manufacturing to intelligent and lean production [4]. - New productive forces enhance production efficiency and product consistency through automation and intelligent equipment, addressing quality control challenges [4]. Group 2: Intelligent Manufacturing Practices of Domestic Brands - The past decade has seen a shift in the cosmetics manufacturing industry from experience-driven to data-driven processes, evolving through three stages: semi-automated, automated, and now data-driven intelligent stages [6]. - Leading brands like Han Shu and Pechoin have made significant investments in intelligent manufacturing, achieving production capacity increases and improved quality control [8][10]. - Domestic brands have made historical advancements in intelligent manufacturing, with automation rates rising from approximately 40% to levels comparable to international brands [10]. Group 3: R&D Innovation and Cost Management - R&D expenditure rates vary across different categories, with skincare products averaging 1.5%-5% and medical beauty products at 2%-5%, reflecting a focus on compliance and clinical data [21][23]. - Domestic brands like Han Shu and Pechoin have R&D personnel ratios comparable to international leaders, indicating strong R&D capabilities [24]. - The production cost rates for various product categories range from 15% to 30%, with domestic brands leveraging self-researched technologies and integrated supply chains to maintain competitive pricing [27][28]. Group 4: International Competitiveness of Domestic Brands - Domestic brands have achieved significant breakthroughs in the cosmetics sector, enhancing core competitiveness through new productive forces [31]. - Intelligent manufacturing has enabled micro-level quality control, establishing trust in product quality [33]. - The integration of AI and 5G technologies in manufacturing processes positions domestic brands at the forefront of global standards, driving high-quality development in the industry [33].

Core Insights - The global beauty industry is entering a transformation phase, with average growth slowing from 7% (2022-2024) to 5% (2025-2030), indicating a shift towards a more complex and segmented market focused on high-end and fragrance products [1][3][25]. Group 1: Major Corporate Movements - L'Oréal's acquisition of Kering's high-end beauty business for €4 billion is a significant event, expanding L'Oréal's presence in the luxury beauty and fragrance market while allowing Kering to focus on its core fashion business [1][5][11]. - L'Oréal has been active in the beauty capital market with six major global transactions this year, including acquisitions and minority investments, enhancing its portfolio in high-end and trendy markets [5][6][7][11]. - Estée Lauder is undergoing a restructuring plan to focus on high-end fragrances, with a new innovation center in Paris aimed at improving efficiency and product development [12][14]. Group 2: Market Trends and Dynamics - The beauty industry is witnessing a shift from product competition to capital and licensing restructuring, with leading groups focusing on mergers and acquisitions to strengthen their positions in luxury fragrances and high-end segments [3][4][25]. - The rise of domestic brands in China, such as Perfect Diary and Huaxizi, is attributed to the growing interest from Gen Z consumers and effective online marketing strategies, leading to a 10.1% year-on-year growth in the beauty market [18][19][25]. - The trend towards high-end and fragrance products is becoming a growth highlight, with luxury fragrances showing nearly 10% business growth, indicating consumers' willingness to pay for premium beauty experiences [26][29]. Group 3: Strategic Adjustments by Companies - Shiseido is implementing a two-year action plan to rebuild profits through cost-cutting and operational efficiency, successfully turning a previous loss into a profit in its latest financial report [14][15]. - Coty faces significant risks due to the impending expiration of its Gucci licensing agreement in 2028, prompting a strategic review and a focus on fragrance business growth [15][25]. - Consumer goods giants like Unilever and Procter & Gamble are steadily expanding their beauty and personal care segments, with Unilever acquiring several natural and functional brands to enhance its portfolio [17][25]. Group 4: Future Industry Trends - The beauty industry is expected to see continued acceleration in mergers and asset restructuring, with both global giants and local brands adapting to market fluctuations [25][26]. - Digitalization and technological advancements are becoming key competitive factors, with brands leveraging AI and online channels to enhance customer engagement and product offerings [27][29]. - The overall transformation in the beauty industry is characterized by a focus on high-end products, technological innovation, and global expansion, with domestic brands poised to lead in the international market [25][29].

Core Insights - The Hong Kong stock market is experiencing a significant resurgence in 2025, with 114 new IPOs and a total fundraising amount of 286.3 billion HKD, marking a 63% increase in new listings and over 200% growth in fundraising compared to 2024, reclaiming the top position in global IPOs after four years [1][3][26] IPO Market Performance - The year 2025 saw a total of 114 new stocks listed on the Hong Kong Stock Exchange, a substantial increase from 70 in 2024 [1][3] - The total fundraising amount reached 286.3 billion HKD, representing a growth of over 200% year-on-year [1][3] - Eight new stocks raised over 10 billion HKD each, with Ningde Times raising 41 billion HKD, becoming the second-largest IPO globally [3] New Stock Subscription Records - The market witnessed record-breaking subscription rates, with Jin Ye International Group achieving a subscription multiple of 11,465 times, the highest in Hong Kong's history [4] - The IPO of Mixue Group saw a frozen capital scale of 1.84 trillion HKD, making it the "frozen capital king" of Hong Kong IPOs [4] - The IPO failure rate dropped to 28.83%, the lowest in five years, indicating a strong market sentiment [4] Company Listings and Trends - The new listings in 2025 can be categorized into three tiers: new consumer brands, A+H listed companies, and resilient companies transitioning from A-share failures [5][6][8] - New consumer brands like Mixue Group and Lin Qingxuan have shown strong market performance, with Mixue Group's market value reaching 109.3 billion HKD [7][8] - A+H listed companies contributed significantly to the IPO recovery, with 19 such companies raising about 50% of the total fundraising [8] Market Dynamics and Future Outlook - The IPO market is expected to remain active in 2026, with over 300 applications pending, predicting around 160 new listings and a total fundraising of at least 300 billion HKD [15][18] - The influx of southbound capital and selective foreign investment is reshaping the market structure, with domestic investors gaining significant pricing power [22][24] - The trend of A-share companies seeking dual listings in Hong Kong is likely to continue, supported by favorable policies encouraging domestic companies to list abroad [17][18] Capital Market Evolution - The capital market is witnessing a shift in funding structure, with southbound capital net purchases reaching nearly 1.41 trillion HKD, a record high [22] - The integration of companies into the Hong Kong Stock Connect is enhancing liquidity and valuation, creating a positive cycle for listed firms [22][24] - Companies are increasingly focusing on operational efficiency and sustainable growth to attract capital, moving away from mere storytelling [20][21]

Investment Rating - The report maintains a "Positive" investment rating for the beauty and personal care industry, specifically focusing on PDRN applications [6]. Core Insights - The report highlights that PDRN (Polydeoxyribonucleotide) is expected to unleash stronger commercial potential due to increasing registrations and search metrics. The extraction of PDRN is transitioning from animal sources to microbial fermentation and synthetic biology, laying a solid foundation for accelerated applications in the medical beauty and skincare sectors [3][4]. - The report emphasizes that domestic beauty companies are likely to redefine the value boundaries of PDRN, with leading firms accelerating their strategies in this competitive landscape [3][4]. Summary by Sections PDRN Overview - PDRN, derived from salmon and other sources, has a high similarity to human DNA (98%) and is known for its skin repair and cell regeneration properties. Its historical development spans from the 15th century to its current applications in medical aesthetics and cosmetics [8][13][19]. Market Growth Potential - The PDRN market is projected to grow significantly, with estimates indicating an increase from USD 0.72 billion in 2024 to USD 8.55 billion by 2031, reflecting a CAGR of 43%. The demand for anti-aging products is a core driver of this growth [8][30]. Competitive Landscape - Domestic companies are actively entering the PDRN medical and skincare sectors, with significant advancements in extraction technologies. Companies like Huaxi Biological and Lepu Medical are leading the charge in developing PDRN-based products [8][30][34]. Key Mechanisms and Benefits - PDRN operates through two main mechanisms: acting as an agonist for the adenosine A2A receptor to suppress inflammation and providing nucleotides for DNA synthesis, thus promoting cell regeneration and tissue repair [34][36]. - The primary benefits of PDRN include skin repair, anti-inflammatory effects, and anti-aging properties, making it suitable for various cosmetic and medical applications [34][39].

1. Report's Investment Rating for the Industry - No information provided regarding the industry's investment rating. 2. Core Views of the Report - Bullish on the equity market during the "Spring Rally". With the expected strengthening of underlying stocks and seasonal effects, there is a slight room for convertible bond valuations to increase. When selecting bonds, focus on the performance elasticity of the underlying stocks. For near - maturity convertible bonds, consider participating in the underlying stocks [27]. - In the stock market, in December 2025, the risk appetite was high. Looking ahead, the RMB appreciation expectation is strengthening, and with the end of the year - end ranking assessment of financial institutions, the "Spring Rally" is expected to gradually kick off. In January, if the market adjusts during the intensive performance forecast period, investors can buy on dips and focus on resources, AI computing power, batteries, polyester industry chain, AI edge devices, and securities [27]. - In the convertible bond market, in December 2025, the CSI Convertible Bond Index reached a new high since July 2015. Although the share of convertible bond ETFs continued to decline, the market premium rate increased. In the future, due to seasonal effects, some institutional investors may gradually increase their positions in January, and convertible bond valuations have a slight room for improvement [27]. 3. Summary of Each Section 3.1 2025 December Convertible Bond Market Review - **Stock and Bond Market Review**: In December, the equity market fluctuated upwards, and the bond market generally fluctuated. The Shanghai Composite Index rose for nearly 10 consecutive trading days in the middle and late - December, closing at 3963.68 on December 26, with a monthly increase of 1.27%. The 10 - year Treasury bond yield closed at 1.838% on December 26, up 0.10bp from the beginning of the month, and the 30 - year Treasury bond yield closed at 2.223%, up 3.32bp from the beginning of the month [4][8]. - **Convertible Bond Market Review**: The convertible bond market generally rose following the equity market. The premium rates of convertible bonds in all parity ranges increased, but convertible bond ETFs continued to face outflow pressure. Five convertible bonds announced downward revisions, one more than the previous month, and 10 convertible bonds announced forced redemptions, two less than the previous month. The CSI Convertible Bond Index closed at 493.2 on December 26, up 2.31% [5][8]. - **Industry Performance**: In the Shenwan industry classification, sectors such as national defense and military industry (+12.25%), communication (+10.55%), and non - bank finance (+8.27%) performed well, while sectors such as media (-4.77%), banks (-3.68%), and coal (-3.62%) declined [8]. 3.2 2026 January Convertible Bond Allocation Strategy - **Stock Market Outlook**: The RMB appreciation expectation is strengthening, and the "Spring Rally" is expected to start. In January, if the market adjusts during the performance forecast period, investors can buy on dips. Focus on resources, AI computing power, batteries, polyester industry chain, AI edge devices, and securities [27]. - **Convertible Bond Outlook**: Due to seasonal effects, some institutions may increase their positions in January. Convertible bond valuations have a slight room for improvement. When selecting bonds, relative - return funds should focus on high - probability sectors with a high - beta underlying stocks, and absolute - return funds should focus on high - odds sectors [27][28]. - **Bond Selection Suggestions**: For relative - return funds, focus on sectors such as lithium - battery materials, semiconductor equipment and materials, power semiconductors, high - quality auto parts, anti - involution industries, and securities. For absolute - return funds, focus on industry leaders with low valuations, sectors such as pig farming, power, and water supply, and convertible bond debt - to - equity conversion [28]. 3.3 2026 January "Top Ten Convertible Bonds" Portfolio | Convertible Bond Code | Convertible Bond Name | Underlying Stock Name | Industry | Balance (Billion Yuan) | Convertible Bond Price (Yuan) | Convertible Bond Parity (Yuan) | Conversion Premium Rate (%) | Rating | Recommendation Reason | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 113043.SH | Caitong Convertible Bond | Caitong Securities | Securities II | 37.99 | 133.52 | 109.71 | 21.70 | AAA | The securities sector will see a double - hit of valuation and profit in a bull market [30]. | | 123254.SZ | EVE Convertible Bond | EVE Energy | Battery | 49.98 | 167.64 | 134.65 | 24.51 | AA+ | The demand for energy storage is strong, and the shipment volume in the third quarter increased significantly year - on - year and quarter - on - quarter [30]. | | 113695.SH | Huachen Convertible Bond | Jiangsu Huachen | Power Grid Equipment | 4.60 | 160.16 | 122.10 | 31.17 | A+ | The company's new production capacity is put into operation just as the demand for energy storage is growing rapidly [30]. | | 113634.SH | Proya Convertible Bond | Proya | Cosmetics | 7.51 | 125.13 | 70.36 | 77.83 | AA | As a domestic beauty leader, its brand and product strength are outstanding, and its valuation at a historical low is expected to be restored [30]. | | 113616.SH | Will Semiconductor Convertible Bond | Will Semiconductor | Semiconductor | 24.32 | 124.07 | 78.35 | 58.36 | AA+ | The company is accelerating its introduction into intelligent driving and emerging markets and has launched new mobile phone products with strong competitiveness [30]. | | 118040.SH | Hongwei Convertible Bond | Hongwei Technology | Semiconductor | 4.30 | 149.72 | 116.17 | 28.88 | A | Power semiconductors benefit from the growth of power supply and energy storage demand [30]. | | 113674.SH | Huashe Convertible Bond | Huashe Group | Engineering Consulting Service II | 4.00 | 129.29 | 89.47 | 44.51 | AA | As a leader in infrastructure design, its main business is stabilizing, and intelligent design and low - altitude economy provide growth points [30]. | | 123222.SZ | Bojun Convertible Bond | Bojun Technology | Auto Parts | 2.44 | 224.63 | 194.72 | 15.36 | A+ | The growth of customer sales and the increase in ASP per vehicle drive up revenue and profit [30]. | | 113666.SH | Aima Convertible Bond | Aima Technology | Motorcycle and Others | 19.99 | 125.11 | 79.63 | 57.12 | AA | The new national standard may promote the market share of the two - wheeled vehicle leader [30]. | | 123247.SZ | Wankai Convertible Bond | Wankai New Materials | Plastics | 19.64 | 172.30 | 150.18 | 14.73 | AA | Under the "anti - involution" of bottle chips, the processing fee is expected to stabilize, and the company is entering the rPET blue - ocean market [30]. |